statements

Gujarat Inject (Kerala) Ltd.

BSE: 524238

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

10.50+0.5 (+5.00%)

7 Aug, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Gujarat Inject (Kerala) Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	-	-	0.01	0.02	0.17	5.79	19.05	36.32	46.35
Cost of Operating Revenue	-	-	0.01	0.02	0.15	5.40	17.78	33.62	42.05
Gross Profit	-	-	0.00	0.01	0.02	0.39	1.27	2.70	4.30
Gross Margin	-	-	22.8	31.3	11.5	6.7	6.7	7.4	9.3
Total Operating Expenses	0.02	0.01	0.13	0.07	0.55	5.74	17.97	34.01	42.46
Operating Profit	-0.02	-0.01	-0.11	-0.05	-0.38	0.04	1.08	2.31	3.90
Operating Margin	-	-	-982.3	-200.2	-217.0	0.8	5.6	6.4	8.4
Financing Income/(Expense) - Net	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00
Profit before Taxes	-0.01	0.00	-0.11	0.00	0.06	0.11	1.25	2.50	4.09
Income Taxes	-	-	-	0.00	0.01	0.02	0.24	0.69	1.10
Profit after Tax	-0.01	0.00	-0.11	0.00	0.04	0.08	1.02	1.81	2.99
PAT Margin	-	-	-911.3	9.8	23.6	1.4	5.3	5.0	6.5
EPS - Basic - ex Extraordinary Items	-0.01	0.00	-0.21	0.00	0.08	0.09	0.69	1.24	0.21
EPS - Diluted - ex Extraordinary Items	-0.01	0.00	-0.21	0.00	0.08	0.09	0.69	1.24	0.21
EBIT	-0.02	-0.01	-0.11	-0.05	-0.38	0.04	1.08	2.31	3.90
EBITDA	-0.02	-0.01	-0.11	-0.05	-0.38	0.04	1.08	2.31	3.90
EBITDA Margin	-	-	-982.3	-200.2	-217.0	0.8	5.6	6.4	8.4

Balance Sheet

Abridged

Understanding Balance Sheet

Gujarat Inject (Kerala) Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	C 2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	0.01	0.01	0.01	0.02	0.07	8.69	9.98	11.56
Long-Term Investments	0.00	0.00	0.00	0.00	-	-	-	0.01
Property Plant & Equipment - Net	-	-	-	-	-	-	-	20.76
Total Non-Current Assets	0.00	0.00	0.01	0.04	0.23	-	1.98	25.10
Total Assets	0.01	0.01	0.02	0.06	0.30	8.69	11.95	36.67
Total Current Liabilities	0.48	0.48	0.48	0.53	0.68	0.14	1.94	24.84
Long Term Debt	0.31	0.31	0.42	0.42	0.46	-	-	-
Total Non-Current Liabilities	0.31	0.31	0.42	0.42	0.46	-	-	-
Total Liabilities	0.79	0.79	0.90	0.94	1.14	0.14	1.94	24.84
Total Shareholders' Equity	-0.78	-0.78	-0.88	-0.88	-0.84	8.55	10.01	11.83
Total Equity	-0.78	-0.78	-0.88	-0.88	-0.84	8.55	10.01	11.83
Total Liabilities & Equity	0.01	0.01	0.02	0.06	0.30	8.69	11.95	36.67

Cash Flow

Abridged

Understanding Cash Flow Statement

Gujarat Inject (Kerala) Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-0.01	0.00	-0.11	0.00	0.04	0.08	1.02	2.43
Working Capital - Increase/(Decrease)	0.01	-	0.00	0.00	0.01	-6.11	-2.38	18.98
Net CF from Operating Activities	0.00	0.00	-0.11	0.00	0.05	-6.03	-1.37	21.42
Capital Expenditures - Net	-	-	-	-	-	-	-	20.76
Net CF from Investing Activities	-	-	-	-	0.00	-	-	-20.76
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	9.30	0.45	-
Debt - LT & ST - Issuance/(Retirement) - Total	-	-	0.10	-	-	-0.42	-	-
Net Cash Flow from Financing Activities	-	-	0.10	-	-	8.88	-1.53	-
Free Cash Flow to Equity	0.00	0.00	0.00	0.00	0.05	-6.44	-1.37	0.65
Free Operating CF net dividend	0.00	0.00	-0.11	0.00	0.05	-6.03	-1.37	0.65
Free Operating CF	0.00	0.00	-0.11	0.00	0.05	-6.03	-1.37	0.65

Business Segment Analysis

Gujarat Inject (Kerala) Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Gujarat Inject (Kerala) Ltd.

Regional Segment Analysis

Gujarat Inject (Kerala) Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Gujarat Inject (Kerala) Ltd.

Historical Segment Analysis

Track how Gujarat Inject (Kerala) Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Gujarat Inject (Kerala) Ltd.

Frequently Asked Questions

What is the revenue of Gujarat Inject (Kerala) Ltd.?

The latest trailing twelve month revenue of Gujarat Inject (Kerala) Ltd. is ₹ 46.35 Cr, reflecting a 1-year growth of 151.63% and a 3-year CAGR of 445.11%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Gujarat Inject (Kerala) Ltd.?

The latest trailing twelve month net profit (PAT) of Gujarat Inject (Kerala) Ltd. is ₹ 2.99 Cr, with a 3-year earnings CAGR of 146.22%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Gujarat Inject (Kerala) Ltd.?

The trailing twelve month EBITDA of Gujarat Inject (Kerala) Ltd. is approximately ₹ 3.90 Cr (based on an operating margin of 8.41%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Gujarat Inject (Kerala) Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Gujarat Inject (Kerala) Ltd. is 0.21. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Gujarat Inject (Kerala) Ltd.?

The debt-to-equity ratio of Gujarat Inject (Kerala) Ltd. stands at 0.00. The interest coverage ratio is 11,540.00x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Gujarat Inject (Kerala) Ltd.?

The estimated book value per share of Gujarat Inject (Kerala) Ltd. is 0.81 (derived from a P/B ratio of 13.00 and market price of ₹ 10.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Gujarat Inject (Kerala) Ltd.?

The trailing twelve month operating cash flow of Gujarat Inject (Kerala) Ltd. is ₹ 21.42 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Gujarat Inject (Kerala) Ltd. report consolidated or standalone financials?

Gujarat Inject (Kerala) Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.